Trial site
Swedish Cancer Institute
- 53running trials
- 18closed trials
The trials here
What the 72 trials at this site are about, from their registry records.
- Conditions
- Lung cancer19 trials
- Diffuse large B-cell lymphoma11 trials
- Mantle cell lymphoma9 trials
- Multiple myeloma9 trials
- Follicular lymphoma8 trials
- Acute myeloid leukaemia7 trials
- Chronic lymphocytic leukaemia7 trials
- Colorectal cancer7 trials
- Bladder cancer6 trials
- Endometrial cancer6 trials
- Gastric and oesophageal cancer6 trials
- Ovarian cancer6 trials
- and 20 more
- Phase
- Phase 320 trials
- Phase 117 trials
- Phase 216 trials
- Phase 1/212 trials
- Phase 44 trials
- Phase 2/32 trials
- Status
- Recruiting26 trials
- Active, not recruiting25 trials
- Completed13 trials
- Terminated5 trials
- Enrolling by invitation1 trial
- Not yet recruiting1 trial
- Suspended1 trial
- Lead sponsor
- Janssen Research & Development, LLC7 trials
- Kite, A Gilead Company5 trials
- IDEAYA Biosciences4 trials
- Pfizer4 trials
- Celgene3 trials
- and 35 more
Running trials
Recruiting
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Recruiting
Recruiting
Recruiting
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
Recruiting
Recruiting
Recruiting
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
Recruiting
Recruiting
Recruiting
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
Recruiting
Recruiting
A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
Recruiting
Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)
Recruiting
Active, not recruiting
Recruiting
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Active, not recruiting
Study of NXC-201 CAR-T in Patients With Light Chain (AL) Amyloidosis
Active, not recruiting
Active, not recruiting
Study Evaluating SC262 in Subjects With r/r Non-Hodgkin's Lymphoma (VIVID)
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2
Active, not recruiting
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
Recruiting
Recruiting
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
Active, not recruiting
A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors
Active, not recruiting
A Study of Botensilimab and Balstilimab for the Treatment of Colorectal Cancer
Recruiting
Active, not recruiting
Recruiting
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
Enrolling by invitation
Long-Term Follow-Up Study After Gene-Modified Cell Treatment in Kite Studies
Recruiting
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
Active, not recruiting
Study of IDE397 in Participants With Solid Tumors Harboring MTAP Deletion
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies
Recruiting
Active, not recruiting
A Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid Tumors
Active, not recruiting
Recruiting
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Recruiting
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma
Recruiting
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Active, not recruiting
Aggressive Smoldering Curative Approach Evaluating Novel Therapies and Transplant
Active, not recruiting
Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC
Active, not recruiting
Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.
Recruiting
Showing 50 of 53.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer7 recruiting
- Childhood cancers4 recruiting
- Colorectal cancer4 recruiting
- Bladder cancer3 recruiting
- Chronic lymphocytic leukaemia3 recruiting
- Diffuse large B-cell lymphoma3 recruiting
- Gastric and oesophageal cancer3 recruiting
- Ovarian cancer3 recruiting
- Endometrial cancer2 recruiting
- Mantle cell lymphoma2 recruiting
- Mesothelioma2 recruiting
- Multiple myeloma2 recruiting
- Pancreatic cancer2 recruiting
- Prostate cancer2 recruiting
- Acute myeloid leukaemia1 recruiting
- Cervical cancer1 recruiting
- Crohn's disease1 recruiting
- Follicular lymphoma1 recruiting
- Head and neck cancer1 recruiting
- Melanoma1 recruiting
- Metastatic breast cancer1 recruiting
- Myeloproliferative neoplasms1 recruiting
- Neuroendocrine tumours1 recruiting
Closed trials
Completed
A Study of Botensilimab in Participants With Metastatic Pancreatic Cancer
Terminated
A Study of CNTY-101 in Participants With CD19-Positive B-Cell Malignancies
Terminated
A Study of HC-7366 to Establish the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D)
Recruiting
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Completed
Completed
Terminated
Terminated
Completed
Completed
Study of Ibrutinib Combined With Venetoclax in Subjects With Mantle Cell Lymphoma (MCL)
Completed
Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma
Completed
Completed
A Study of TAK-788 in Adults With Non-Small Cell Lung Cancer
Completed
Recruiting
Selinexor and Backbone Treatments of Multiple Myeloma Patients
Recruiting
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer
Terminated
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026